CS
GILD icon

Comerica Securities’s Gilead Sciences GILD Stock Holding History

Comerica Securities’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,433
Closed -$265K – 460
2023
Q2 		$265K Sell
3,433
-2,280
-40% -$182K 0.02% 403
2023
Q1 		$474K Sell
5,713
-5,135
-47% -$425K 0.03% 304
2022
Q4 		$931K Buy
10,848
+3,387
+45% +$268K 0.07% 245
2022
Q3 		$460K Buy
7,461
+1,484
+25% +$93.6K 0.04% 284
2022
Q2 		$369K Buy
5,977
+963
+19% +$59.6K 0.03% 343
2022
Q1 		$298K Buy
5,014
+594
+13% +$38K 0.02% 404
2021
Q4 		$321K Sell
4,420
-1,829
-29% -$126K 0.02% 408
2021
Q3 		$436K Buy
6,249
+62
+1% +$4.36K 0.03% 335
2021
Q2 		$426K Sell
6,187
-1,559
-20% -$104K 0.03% 336
2021
Q1 		$501K Sell
7,746
-2,121
-21% -$137K 0.04% 317
2020
Q4 		$575K Sell
9,867
-2,823
-22% -$170K 0.05% 277
2020
Q3 		$802K Buy
12,690
+1,609
+15% +$112K 0.07% 211
2020
Q2 		$853K Sell
11,081
-5,390
-33% -$413K 0.08% 199
2020
Q1 		$1.23M Sell
16,471
-233
-1% -$16.1K 0.14% 141
2019
Q4 		$1.08M Buy
16,704
+536
+3% +$34.9K 0.1% 186
2019
Q3 		$1.02M Buy
16,168
+8,506
+111% +$556K 0.11% 184
2019
Q2 		$518K Sell
7,662
-29,435
-79% -$1.94M 0.06% 267
2019
Q1 		$2.41M Sell
37,097
-4,139
-10% -$275K 0.27% 91
2018
Q4 		$2.58M Sell
41,236
-6,444
-14% -$450K 0.34% 75
2018
Q3 		$3.68M Buy
47,680
+12,220
+34% +$923K 0.43% 64
2018
Q2 		$2.51M Buy
35,460
+42
+0.1% +$2.97K 0.3% 101
2018
Q1 		$2.67M Sell
35,418
-1,643
-4% -$131K 0.33% 87
2017
Q4 		$2.65M Sell
37,061
-4,932
-12% -$375K 0.33% 89
2017
Q3 		$3.4M Buy
41,993
+38,035
+961% +$2.91M 0.47% 57
2017
Q2 		$280K Sell
3,958
-3,074
-44% -$205K 0.04% 329
2017
Q1 		$478K Buy
+7,032
New +$494K 0.08% 256
2015
Q3 		– Sell
-26,230
Closed -$3.07M – 244
2015
Q2 		$3.07M Buy
26,230
+2,149
+9% +$235K 0.76% 22
2015
Q1 		$2.36M Buy
+24,081
New +$2.45M 0.61% 64

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Comerica Securities's GILD Position: Q3 2023 in Review

Comerica Securities sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 3,433 shares — an estimated $265K sold.

Comerica Securities first reported a position in GILD in Q1 2015 and held it in 28 quarters. The position peaked at $3.68M in Q3 2018. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

  • Comerica Securities reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
  • Comerica Securities sold 3,433 Gilead Sciences shares in Q3 2023, an estimated $265K.
  • Comerica Securities first reported a position in Gilead Sciences in Q1 2015 and held it in 28 quarters.
  • Comerica Securities's Gilead Sciences position peaked at $3.68M in Q3 2018.
  • 1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Comerica Securities's 13F filing for Q3 2023, filed 26 Oct 2023.